Tomii A, Masugi F
Department of Medicine and Geriatrics, Osaka University Medical School, Japan.
Jpn J Med Sci Biol. 1991 Apr;44(2):75-80. doi: 10.7883/yoken1952.44.75.
Polyclonal and monoclonal antibodies to platelet-activating factor (PAF) were produced, by use of colloidal gold as the hapten carrier. These polyclonal (R88-09) and monoclonal (602 B11) antibodies both reacted with PAF, lysoplatelet-activating factor (lyso PAF), and L-alpha-lysophosphatidylcholine, palmitoyl (lyso PCP), but did not react with phosphorylcholine chloride (PCC). Their affinities were higher for PAF than lyso PAF and lyso PCP.
利用胶体金作为半抗原载体,制备了针对血小板活化因子(PAF)的多克隆抗体和单克隆抗体。这些多克隆抗体(R88 - 09)和单克隆抗体(602 B11)均能与PAF、溶血血小板活化因子(lyso PAF)、L-α-溶血磷脂酰胆碱、棕榈酰(lyso PCP)发生反应,但不与氯化磷酰胆碱(PCC)反应。它们对PAF的亲和力高于lyso PAF和lyso PCP。